Search Results - "population pharmacokinetics"

Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC) by Oneeb Majid, Seiichi Hayato, Sree Harsha Sreerama Reddy, Bojan Lalovic, Taro Hihara, Taisuke Hoshi, Yasuhiro Funahashi, Jagadeesh Aluri, Osamu Takenaka, Sanae Yasuda, Ziad Hussein

Connect to this object online.

Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir, in Human Subjects Using Population Pharmacokinetic (PK) Analysis by Adrienne Carmel Muller, Murray P Ducharme, Isadore Kanfer

Connect to this object online.

Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets by Franke RM, Morton T, Devarakonda K

Connect to this object online.

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i> by Pier Giorgio Cojutti, Anna Candoni, Davide Lazzarotto, Carla Filì, Maria Zannier, Renato Fanin, Federico Pea

Connect to this object online.

Combined carbapenem resulted in a 4.48-fold increase in valproic acid clearance: a population pharmacokinetic model in Chinese children and adults with epilepsy or after neurosurgery by Luofei Zhang, Luofei Zhang, Ruoyun Wu, Ruoyun Wu, Xingmeng Li, Weixing Feng, Zhigang Zhao, Zhigang Zhao, Shenghui Mei, Shenghui Mei

Connect to this object online.

Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients by Jaydeep K. Srimani, Paul M. Diderichsen, Michael J. Hanley, Karthik Venkatakrishnan, Richard Labotka, Neeraj Gupta

Connect to this object online.

Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children's medical center by Yewei Chen, Jianger Lan, Lin Zhu, Min Dong, Min Dong, Yi Wang, Zhiping Li

Connect to this object online.

Non-Linear Pharmacokinetics of Oral Roscovitine (Seliciclib) in Cystic Fibrosis Patients Chronically Infected with <i>Pseudomonas aeruginosa</i>: A Study on Population Pharmacokinetics with Monte Carlo Simulations by Cyril Leven, Sacha Schutz, Marie-Pierre Audrezet, Emmanuel Nowak, Laurent Meijer, Tristan Montier

Connect to this object online.

Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation-A 10-Year Single-Center Experience by Katharina M. Schreib, Dominic S. Bräm, Ulrike Barbara Zeilhofer, Daniel Müller, Tayfun Güngör, Stefanie D. Krämer, Mathias M. Hauri-Hohl

Connect to this object online.

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations by Qianting Yang, Tao Zhang, Ying Zhang, Dan Sun, Dan Sun, Xiaowei Zheng, Xiaowei Zheng, Qian Du, Xue Wang, Xue Wang, Xiaoliang Cheng, Jianfeng Xing, Jianfeng Xing, Yalin Dong

Connect to this object online.

Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study by Baohua Xu, Ting Yang, Jianxing Zhou, You Zheng, Jingting Wang, Qingxia Liu, Dandan Li, Yifan Zhang, Maobai Liu, Xuemei Wu

Connect to this object online.

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization by Pier Giorgio Cojutti, Milo Gatti, Milo Gatti, Matteo Rinaldi, Matteo Rinaldi, Tommaso Tonetti, Tommaso Tonetti, Cristiana Laici, Chiara Mega, Chiara Mega, Antonio Siniscalchi, Maddalena Giannella, Maddalena Giannella, Pierluigi Viale, Pierluigi Viale, Federico Pea, Federico Pea

Connect to this object online.

<i>CYP3A5*3</i> and <i>CYP3A4*22</i> Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach by Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas

Connect to this object online.

Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation-A Step toward Correct Dosing by Dragana Milaković, Tijana Kovačević, Pedja Kovačević, Vedrana Barišić, Sanja Avram, Saša Dragić, Biljana Zlojutro, Danica Momčičević, Branislava Miljković, Katarina Vučićević

Connect to this object online.

Population pharmacokinetics of FCN-159, a MEK1/2 inhibitor, in adult patients with advanced melanoma and neurofibromatosis type 1 (NF1) and model informed dosing recommendations for NF1 pediatrics by Yan Tan, Ailing Cui, Lixuan Qian, Chao Li, Zhuli Wu, Yuchen Yang, Pu Han, Xin Huang, Lei Diao

Connect to this object online.

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against <i>Aspergillus fumigatus</i> and <i>Aspergillus flavus</i> in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles? by Pier Giorgio Cojutti, Alessia Carnelutti, Davide Lazzarotto, Emanuela Sozio, Anna Candoni, Renato Fanin, Carlo Tascini, Federico Pea

Connect to this object online.

Drug Metabolism/Transport and Pharmacokinetics

Subjects: “…population pharmacokinetic…”
DOAB: download the publication
DOAB: description of the publication

Celebrating Applied Sciences Reaches 20,000 Articles Milestone Feature Papers in Applied Biosciences and Bioengineering Section

Subjects: “…population pharmacokinetic modeling…”
DOAB: download the publication
DOAB: description of the publication

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine by Richard Khusial, Robert R. Bies, Ayman Akil

Connect to this object online.

Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures by Jae Won Shin, Yun Seob Jung, Kyungsoo Park, Soon Min Lee, Ho Seon Eun, Min Soo Park, Kook In Park, Ran Namgung

Connect to this object online.